发明申请
- 专利标题: FACTOR IXa INHIBITORS
- 专利标题(中): 因子IXa抑制剂
-
申请号: US15303322申请日: 2015-04-10
-
公开(公告)号: US20170027916A1公开(公告)日: 2017-02-02
- 发明人: Isao Sakurada , Tomokazu Hirabayashi , Yoshitaka Maeda , Hiroshi Nagasue , Takashi Mizuno , Jiayi Xu , Ting Zhang , Cameron Smith , Dann Parker
- 申请人: Merck Sharp & Dohme Corp. , Mochida Pharmaceutical Co., Ltd.
- 申请人地址: US NJ Rahway JP Tokyo
- 专利权人: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- 当前专利权人: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- 当前专利权人地址: US NJ Rahway JP Tokyo
- 国际申请: PCT/US2015/025219 WO 20150410
- 主分类号: A61K31/439
- IPC分类号: A61K31/439 ; A61K45/06 ; A61K31/444 ; A61K31/506 ; A61K31/501 ; C07D519/00 ; C07D413/14 ; C07D498/04
摘要:
In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
公开/授权文献
- US09808445B2 Factor IXa inhibitors 公开/授权日:2017-11-07
信息查询
IPC分类: